Director, Clinical Supply

Company hidden

Remote, US Remote Posted 30+ days ago
The company is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. The company’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 3 PHrontier global clinical trial in PH-ILD, but with potential broad…

See the company and apply

Unlock to see who’s hiring, read the full description and apply on the company site.

Checking access…

Explore related jobs

Want more roles like this? Browse fresh jobs or tailor your resume with AI.